Investigation Overview
September 25, 2015 (Shareholders Foundation) - An investigation on behalf of investors of Raptor Pharmaceutical Corp. (NASDAQ:RPTP) shares over potential securities laws violations by Raptor Pharmaceutical and certain of its directors and officers in connection certain financial statements was announced. The investigation by a law firm focuses on possible claims on behalf of purchase...
You must register (for free) or login to view the entire investigation.